Featured news
Kincell Bio Inc., a cell therapy contract development and manufacturing organization, today announced the signing of a memorandum of understanding with the Duke University School.
Cell therapies hold curative potential, yet far too many patients still can’t access them. In many cases, these treatments aren’t pursued by developers because science...
Kincell Bio announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class immune tolerance platform based on epigenetically reprogrammed regulatory T cells (Tregs). Under...
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
Schedule a meeting in advance to meet our team and explore how Kincell Bio can accelerate your cell therapy program!
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27713
